NextGen Healthcare, Inc. (NXGN) Q3 2022 Earnings Call Transcript

Oct. 25, 2022 9:37 PM ETNextGen Healthcare, Inc. (NXGN)
SA Transcripts profile picture
SA Transcripts
133.8K Followers

NextGen Healthcare, Inc. (NASDAQ:NXGN) Q3 2022 Earnings Conference Call October 25, 2022 5:00 PM ET

Company Participants

James Hammerschmidt - Senior Vice President, Finance and Investor Relations

David Sides - President and Chief Executive Officer

Jamie Arnold - Chief Financial Officer

Conference Call Participants

Stephanie Davis - SVB Securities

Jack Wallace - Guggenheim

Sean Dodge - RBC Capital Markets

George Hill - Deutsche Bank

Jessica Tassan - Piper Sandler

Jailendra Singh - Truist

Annie Samuel - JPMorgan

Operator

Good day, everyone and welcome to today’s NextGen Healthcare Second Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn today’s program over to James Hammerschmidt, Senior Vice President of Finance and IR. Sir, please begin.

James Hammerschmidt

Thank you, operator. Before we start, please note that we will be making forward-looking statements during the presentation and Q&A part of the call. These statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties. Factors that may cause actual results to materially differ from expectations are detailed in our earnings release and SEC filings. This call will also reference certain non-GAAP financial measures. Information about non-GAAP financial measures, including reconciliation to U.S. GAAP can be found in our earnings release, which is available on our Investor Relations website.

At this time, I’d like to turn the call over to our President and CEO, David Sides.

David Sides

Thank you, James. How time flies. It’s hard to believe I recently passed the 1 year anniversary as CEO at NextGen. It’s also hard to believe that we are more than halfway through fiscal year 2023.

Let me start by saying that we have improved confidence and due to our consistent execution and client results, we are increasing our outlook for the remainder of the year. Our updated guidance

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.